Diagnostic imaging guide for autoimmune pancreatitis.
Autoimmune pancreatitis
Computed tomography
Diagnostic imaging guide
IgG4-related disease
Magnetic resonance imaging
Journal
Japanese journal of radiology
ISSN: 1867-108X
Titre abrégé: Jpn J Radiol
Pays: Japan
ID NLM: 101490689
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
26
03
2020
accepted:
01
04
2020
pubmed:
17
4
2020
medline:
15
12
2020
entrez:
17
4
2020
Statut:
ppublish
Résumé
The International Consensus Diagnosis Criteria for autoimmune pancreatitis (AIP) has been published internationally for the diagnosis of AIP. However, since the revisions in 2006 and 2011, the Clinical Diagnostic Criteria for Autoimmune Pancreatitis 2018 have been published. The criteria were revised based the Clinical Diagnostic Criteria 2011, and included descriptions of characteristic imaging findings such as (1) pancreatic enlargement and (2) distinctive narrowing of the main pancreatic duct. In addition, pancreatic duct images obtained by magnetic resonance cholangiopancreatography as well as conventional endoscopic retrograde pancreatography were newly adopted. The guideline explains some characteristic imaging findings, but does not contain descriptions of the imaging methods, such as detailed imaging parameters and optimal timings of dynamic contrast-enhanced computed tomography/magnetic resonance imaging. It is a matter of concern that imaging methods can vary from hospital to hospital. Although other characteristic findings have been reported, these findings were not described in the guideline. The present paper describes the imaging methods for obtaining optimal images and the characteristic imaging findings with the aim of standardizing image quality and improving diagnostic accuracy when radiologists diagnose AIP in actual clinical settings.
Identifiants
pubmed: 32297064
doi: 10.1007/s11604-020-00971-z
pii: 10.1007/s11604-020-00971-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
591-612Références
Kawa S, Kamisawa T, Notohara K, Fujinaga Y, Inoue D, Koyama T, et al. Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2018: revision of Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2011. Pancreas. 2020;49(1):e13–e1414.
pubmed: 31856100
Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N, Tsuruta K, et al. MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol. 2006;12(18):2919–22.
pubmed: 16718819
pmcid: 4087811
Frulloni L, Scattolini C, Falconi M, Zamboni G, Capelli P, Manfredi R, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104(9):2288–94.
pubmed: 19568232
Negrelli R, Manfredi R, Pedrinolla B, Boninsegna E, Ventriglia A, Mehrabi S, et al. Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings. Eur Radiol. 2015;25(2):359–67.
pubmed: 25106489
Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2014;49(4):567–88.
pubmed: 24639057
Kawa S, Okazaki K, Kamisawa T, Kubo K, Ohara H, Hasebe O, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2014;49(5):765–84.
pubmed: 24664402
Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49(6):961–70.
pubmed: 24639058
Takahashi N, Fletcher JG, Fidler JL, Hough DM, Kawashima A, Chari ST. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol. 2008;190(2):280–6.
pubmed: 18212210
Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Kodama M, et al. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis? Abdom Imaging. 2009;34(3):381–4.
pubmed: 18437450
Park SH, Kim MH, Kim SY, Kim HJ, Moon SH, Lee SS, et al. Magnetic resonance cholangiopancreatography for the diagnostic evaluation of autoimmune pancreatitis. Pancreas. 2010;39(8):1191–8.
pubmed: 20467343
Yanagisawa S, Fujinaga Y, Watanabe T, Maruyama M, Muraki T, Takahashi M, et al. Usefulness of three-dimensional magnetic resonance cholangiopancreatography with partial maximum intensity projection for diagnosing autoimmune pancreatitis. Pancreatology. 2017;17(4):567–71.
pubmed: 28506431
Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology. 2011;260(2):446–53.
pubmed: 21693662
Chandan VS, Iacobuzio-Donahue C, Abraham SC. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis: implications for preoperative diagnosis. Am J Surg Pathol. 2008;32(12):1762–9.
pubmed: 18779731
Fujinaga Y, Kadoya M, Hamano H, Kawa S, Momose M, Kawakami S, et al. Radiologic findings of IgG4-related disease. Curr Immunol Rev. 2011;7(2):186–203.
Sugiyama Y, Fujinaga Y, Kadoya M, Ueda K, Kurozumi M, Hamano H, et al. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer. Jpn J Radiol. 2012;30(4):296–309.
pubmed: 22237599
Muhi A, Ichikawa T, Motosugi U, Sou H, Sano K, Tsukamoto T, et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging. 2012;35(4):827–36.
pubmed: 22069025
Hur BY, Lee JM, Lee JE, Park JY, Kim SJ, Joo I, et al. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging. 2012;36(1):188–97.
pubmed: 22371378
Choi SY, Kim SH, Kang TW, Song KD, Park HJ, Choi YH. Differentiating mass-forming autoimmune pancreatitis from pancreatic ductal adenocarcinoma on the basis of contrast-enhanced MRI and DWI findings. AJR Am J Roentgenol. 2016;206(2):291–300.
pubmed: 26797355
Kamisawa T, Takuma K, Anjiki H, Egawa N, Hata T, Kurata M, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol. 2010;105(8):1870–5.
pubmed: 20216538
Haaga JR, Alfidi RJ, Zelch MG, Meany TF, Boller M, Gonzalez L, et al. Computed tomography of the pancreas. Radiology. 1976;120(3):589–95.
pubmed: 781727
Furuhashi N, Suzuki K, Sakurai Y, Ikeda M, Kawai Y, Naganawa S. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol. 2015;25(5):1366–74.
pubmed: 25433412
Kwon JH, Kim JH, Kim SY, Byun JH, Kim HJ, Lee MG, et al. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase. Eur Radiol. 2019;29(11):5763–71.
pubmed: 31028441
Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol. 1998;170(5):1323–7.
pubmed: 9574610
Kawamoto S, Siegelman SS, Hruban RH, Fishman EK. Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. Radiographics. 2008;28(1):157–70.
pubmed: 18203936
Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233(2):345–52.
pubmed: 15459324
Sun GF, Zuo CJ, Shao CW, Wang JH, Zhang J. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol. 2013;19(23):3634–41.
pubmed: 23801866
pmcid: 3691039
Kim HJ, Kim YK, Jeong WK, Lee WJ, Choi D. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas. Eur Radiol. 2015;25(6):1551–600.
pubmed: 25501271
Lee S, Kim JH, Kim SY, Byun JH, Kim HJ, Kim MH, et al. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Eur Radiol. 2018;28(12):5267–74.
pubmed: 29948075
Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Okai T, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003;98(12):2679–87.
pubmed: 14687817
Ichikawa T, Sou H, Araki T, Arbab AS, Yoshikawa T, Ishigame K, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221(1):107–16.
pubmed: 11568327
Naitoh I, Nakazawa T, Hayashi K, Okumura F, Miyabe K, Shimizu S, et al. Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer. Scand J Gastroenterol. 2012;47(5):607–13.
pubmed: 22416894
Tokoro H, Yamada A, Suzuki T, Kito Y, Adachi Y, Hayashihara H, et al. Usefulness of breath-hold compressed sensing accelerated three-dimensional magnetic resonance cholangiopancreatography (MRCP) added to respiratory-gating conventional MRCP. Eur J Radiol. 2020;122:108765.
pubmed: 31830630
Tamura R, Ishibashi T, Takahashi S. Chronic pancreatitis: MRCP versus ERCP for quantitative caliber measurement and qualitative evaluation. Radiology. 2006;238(3):920–8.
pubmed: 16424235
Kawai Y, Suzuki K, Itoh S, Takada A, Mori Y, Naganawa S. Autoimmune pancreatitis: assessment of the enhanced duct sign on multiphase contrast-enhanced computed tomography. Eur J Radiol. 2012;81(11):3055–60.
pubmed: 22613506
Nishino T, Oyama H, Toki F, Shiratori K. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol. 2010;45(9):988–96.
pubmed: 20396913
Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007;34(12):2088–95.
pubmed: 17713765
Ishii S, Shishido F, Miyajima M, Sakuma K, Shigihara T, Kikuchi K. Whole-body gallium-67 scintigraphic findings in IgG4-related disease. Clin Nucl Med. 2011;36(7):542–5.
pubmed: 21637055
Ozaki Y, Oguchi K, Hamano H, Arakura N, Muraki T, Kiyosawa K, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol. 2008;43(2):144–51.
pubmed: 18306988
Lee TY, Kim MH, Park DH, Seo DW, Lee SK, Kim JS, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol. 2009;193(2):343–8.
pubmed: 19620430
Matsubayashi H, Furukawa H, Maeda A, Matsunaga K, Kanemoto H, Uesaka K, et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology. 2009;9(5):694–9.
pubmed: 19684434
Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40(3):352–8.
pubmed: 21412117
Ohara H, Nakazawa T, Sano H, Ando T, Okamoto T, Takada H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005;31(3):232–7.
pubmed: 16163054
Fujinaga Y, Kadoya M, Kawa S, Hamano H, Ueda K, Momose M, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol. 2010;76(2):228–38.
pubmed: 19581062
Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99(5):932–7.
pubmed: 15128363
Maruyama M, Arakura N, Ozaki Y, Watanabe T, Ito T, Yoneda S, et al. Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients. Int J Rheumatol. 2013;2013:272595.
pubmed: 23762066
pmcid: 3670467
Ito T, Kawa S, Matsumoto A, Kubota K, Kamisawa T, Okazaki K, et al. Risk factors for pancreatic stone formation in type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 624 patients. Pancreas. 2019;48(1):49–544.
pubmed: 30540679
Kuraishi Y, Watanabe T, Muraki T, Ashihara N, Ozawa M, Nakamura A, et al. Effectiveness of steroid therapy for pancreatic cysts complicating autoimmune pancreatitis and management strategy for cyst-related complications. Scand J Gastroenterol. 2019;54(6):773–9.
pubmed: 31164010
Muraki T, Hamano H, Ochi Y, Arakura N, Takayama M, Komatsu K, et al. Corticosteroid-responsive pancreatic cyst found in autoimmune pancreatitis. J Gastroenterol. 2005;40(7):761–6.
pubmed: 16082595
Nishimura N, Tamada K, Wada S, Ohashi A, Hatanaka H, Nakazawa K, et al. Autoimmune pancreatitis associated with a large pancreatic pseudocyst that disappeared after corticosteroid therapy: a case report and literature review. Clin J Gastroenterol. 2009;2(3):199–203.
pubmed: 26192296
Lee NK, Kim S, Kim DU, Seo HI, Kim HS, Jo HJ, et al. Diffusion-weighted magnetic resonance imaging for non-neoplastic conditions in the hepatobiliary and pancreatic regions: pearls and potential pitfalls in imaging interpretation. Abdom Imaging. 2015;40(3):643–62.
pubmed: 25216848
Shigekawa M, Yamao K, Sawaki A, Hara K, Takagi T, Bhatia V, et al. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? J Hepatobiliary Pancreat Sci. 2010;17(3):269–74.
pubmed: 19727541
Fujinaga Y, Lall C, Patel A, Matsushita T, Sanyal R, Kadoya M. MR features of primary and secondary malignant lymphoma of the pancreas: a pictorial review. Insights Imaging. 2013;4(3):321–9.
pubmed: 23512272
pmcid: 3675250
Merkle EM, Bender GN, Brambs HJ. Imaging findings in pancreatic lymphoma: differential aspects. AJR Am J Roentgenol. 2000;174(3):671–5.
pubmed: 10701607
Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut. 2003;52(5):683–7.
pubmed: 12692053
pmcid: 1773660
van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med. 2004;141(11):896–7.
pubmed: 15583245
Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009;33(8):1249–52.
pubmed: 19561447
Saegusa H, Momose M, Kawa S, Hamano H, Ochi Y, Takayama M, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas. 2003;27(1):20–5.
pubmed: 12826901
Taniguchi T, Ko M, Seko S, Nishida O, Inoue F, Kobayashi H, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut. 2004;53(5):770 (author reply -1).
pubmed: 15082601
pmcid: 1774056
Hirano K, Kawabe T, Komatsu Y, Matsubara S, Togawa O, Arizumi T, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J. 2006;36(1):58–61.
pubmed: 16409315
Sugimoto T, Tanaka Y, Morita Y, Kume S, Uzu T, Kashiwagi A. Is tubulointerstitial nephritis and uveitis syndrome associated with IgG4-related systemic disease? Nephrology (Carlton). 2008;13(1):89.
Nakazawa T, Ohara H, Yamada T, Ando H, Sano H, Kajino S, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48(39):625–30.
pubmed: 11462890
Komatsu K, Hamano H, Ochi Y, Takayama M, Muraki T, Yoshizawa K, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci. 2005;50(6):1052–7.
pubmed: 15986853
Watanabe T, Maruyama M, Ito T, Fujinaga Y, Ozaki Y, Maruyama M, et al. Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol. 2013;42(4):325–30.
pubmed: 23496326
Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359(9315):1403–4.
pubmed: 11978339
Zen Y, Kasahara Y, Horita K, Miyayama S, Miura S, Kitagawa S, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am J Surg Pathol. 2005;29(2):275–8.
pubmed: 15644785
Zen Y, Inoue D, Kitao A, Onodera M, Abo H, Miyayama S, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33(12):1886–933.
pubmed: 19898222
Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol. 2007;20(8):884–94.
pubmed: 17571078
Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19(2):474–6.
pubmed: 14736977
Uchiyama-Tanaka Y, Mori Y, Kimura T, Sonomura K, Umemura S, Kishimoto N, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis. 2004;43(3):e18–25.
pubmed: 14981637
Shinji A, Sano K, Hamano H, Unno H, Fukushima M, Nakamura N, et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc. 2004;59(4):506–11.
pubmed: 15044886
Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32(2):197–204.
pubmed: 18223321
Mizushima I, Kasashima S, Fujinaga Y, Notohara K, Saeki T, Zen Y, et al. Clinical and pathological characteristics of IgG4-related periaortitis/periarteritis and retroperitoneal fibrosis diagnosed based on experts' diagnosis. Ann Vasc Dis. 2019;12(4):460–72.
pubmed: 31942203
pmcid: 6957903
Unno H, Saegusa H, Fukushima M, Hamano H. Usefulness of endoscopic observation of the main duodenal papilla in the diagnosis of sclerosing pancreatitis. Gastrointest Endosc. 2002;56(6):880–4.
pubmed: 12447302
Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology. 2007;46(2):463–71.
pubmed: 17634963
Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol. 2011;46(Suppl 1):48–55.
pubmed: 20862498
Yoshimura Y, Takeda S, Ieki Y, Takazakura E, Koizumi H, Takagawa K. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med. 2006;45(15):897–901.
pubmed: 16946571
Watanabe T, Fujinaga Y, Kawakami S, Hatta T, Hamano H, Kawa S, et al. Infraorbital nerve swelling associated with autoimmune pancreatitis. Jpn J Radiol. 2011;29(3):194–201.
pubmed: 21519993
Inoue D, Zen Y, Sato Y, Abo H, Demachi H, Uchiyama A, et al. IgG4-related perineural disease. Int J Rheumatol. 2012;2012:401890.
pubmed: 22523496
pmcid: 3317227
Nakamura A, Funatomi H, Katagiri A, Katayose K, Kitamura K, Seki T, et al. A case of autoimmune pancreatitis complicated with immune thrombocytopenia during maintenance therapy with prednisolone. Dig Dis Sci. 2003;48(10):1968–71.
pubmed: 14627342